Seeing Is Believing
Healthcare - Sector
ZBH is currently covered by 21 analysts with an average price target of $107.68. This is a potential upside of $19.88 (22.64%) from yesterday's end of day stock price of $87.8.
Zimmer Biomet Holdings's activity chart (see below) currently has 686 price targets and 462 ratings on display. The stock rating distribution of ZBH is 40.48% HOLD, 14.29% SELL and 45.24% BUY.
Analysts average stock forecasts to be materialized ratio is 67.71% with an average time for these price targets to be met of 368.23 days.
Highest price target for ZBH is $125, Lowest price target is $86, average price target is $103.76.
Most recent stock forecast was given by MATT MIKSIC from BARCLAYS on 12-Feb-2026. First documented stock forecast 22-Oct-2013.
Currently out of the existing stock ratings of ZBH, 17 are a HOLD (40.48%), 6 are a SELL (14.29%), 19 are a BUY (45.24%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 09-Nov-2020
$100
$12.13 (13.80%)
$104
1 months 12 days ago
(12-Feb-2026)
12/15 (80%)
$4.82 (5.06%)
318
Hold Since 08-Nov-2023
$98
$10.13 (11.53%)
$98
1 months 13 days ago
(11-Feb-2026)
10/15 (66.67%)
$2.39 (2.50%)
222
Hold Since 17-May-2022
$98
$10.13 (11.53%)
$120
1 months 13 days ago
(11-Feb-2026)
12/17 (70.59%)
$2.39 (2.50%)
134
Hold Since 27-May-2022
1 months 14 days ago
(10-Feb-2026)
13/20 (65%)
$34.16 (32.64%)
1044
Buy Since 28-Aug-2023
$112
$24.13 (27.46%)
$112
1 months 14 days ago
(10-Feb-2026)
3/16 (18.75%)
$20.6 (22.54%)
350
What is ZBH (Zimmer Biomet Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on ZBH (Zimmer Biomet Holdings) with a proven track record?
Which analyst has the most public recommendations on ZBH (Zimmer Biomet Holdings)?
Which analyst is the currently most bullish on ZBH (Zimmer Biomet Holdings)?
Which analyst is the currently most reserved on ZBH (Zimmer Biomet Holdings)?